Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"MEK-5"”.

  1. Design and Synthesis of CDK-5 and MEK-5 Inhibitors and Synthesis towards Tubulysin Analogs

    … of CDK-5 were designed and synthesized. MEK-5, a member of the MAPK family, phosphorylates ERK-5 permitting cells to survive oxidative stress. MEK-5 is upregulated in tumor cells and activated by mitogens; inhibition of this enzyme is a potential anti-cancer strategy. Scaffolds from the …

    duquesne Repository record for Design and Synthesis of CDK-5 and MEK-5 Inhibitors and Synthesis towards Tubulysin Analogs (opens in a new tab)

  2. Targeting the MEK5, MEK1/2, and/or PI3K Pathways to Reverse Epithelial to Mesenchymal Transition and Enhance Chemotherapeutic Sensitivity in Breast And Brain Cancers

    … of mitogen activated protein kinase kinase (MEK) 5, the upstream kinase of ERK5, and/or ERK5 promotes drug resistance, the epithelial to mesenchymal transition (EMT), and hormone independence. Once the cancer cells undergo an EMT, they are harder to target and contain, leading to metastases. …

    duquesne Repository record for Targeting the MEK5, MEK1/2, and/or PI3K Pathways to Reverse Epithelial to Mesenchymal Transition and Enhance Chemotherapeutic Sensitivity in Breast And Brain Cancers (opens in a new tab)

  3. Structure Based Ligand Design for Monoamine Transporters and Mitogen Activated Kinase 5

    … sites. For mitogen activated protein kinase 5 (MEK5), given the lack of structural information, a homology model of MEK5 was developed to guide the rational design of inhibitors. Docking of known MEK5 inhibitors into the homology model was performed to understand the inhibitory interaction …

    duquesne Repository record for Structure Based Ligand Design for Monoamine Transporters and Mitogen Activated Kinase 5 (opens in a new tab)